Other mitochondrial metabolism disorders. E88.49 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM E88.49 became effective on October 1, 2018.
Search the full ICD-10 catalog by:
ICD-10-CM Diagnosis Codes
A00.0 | B99.9 | 1. Certain infectious and parasitic dise ... |
C00.0 | D49.9 | 2. Neoplasms (C00-D49) |
D50.0 | D89.9 | 3. Diseases of the blood and blood-formi ... |
E00.0 | E89.89 | 4. Endocrine, nutritional and metabolic ... |
F01.50 | F99 | 5. Mental, Behavioral and Neurodevelopme ... |
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
ICD-10 Code for Mitochondrial metabolism disorder, unspecified- E88. 40- Codify by AAPC.
Mitochondrial dysfunction occurs when the mitochondria don't work as well as they should due to another disease or condition. Many conditions can lead to secondary mitochondrial dysfunction and affect other diseases, including: Alzheimer's disease. Muscular dystrophy. Lou Gehrig's disease.
Common clinical features of mitochondrial disorders include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus. Diabetes mellitus and deafness is also a well-recognized clinical phenotype.
Together, Leigh syndrome and MELAS are the most common mitochondrial myopathies. The prognosis of Leigh syndrome is generally poor, with survival generally being a matter of months after disease onset.
Mitochondrial diseases are not contagious, and they are not caused by anything a person does. They're caused by mutations, or changes, in genes — the cells' blueprints for making proteins.
Parkinson's disease (PD) is a complex neurodegenerative disorder, the aetiology of which is still largely unknown. Overwhelming evidence indicates that mitochondrial dysfunction is a central factor in PD pathophysiology.
There are nine main forms of mitochondrial myopathy: Kearns-Sayre syndrome (KSS)
Mitochondrial disease (mito) is a debilitating and potentially fatal disease that reduces the ability of the mitochondria to produce this energy. When the mitochondria are not working properly, cells begin to die until eventually whole organ systems fail and the patient's life itself is compromised.
Mitochondrial DAMPs are important in triggering and maintaining immune responses. Mitochondrial dysfunction may play a role in the pathophysiology of autoimmune disease.
In the new study, the researchers examined red blood cells, which are supposed to have no mitochondria at all. They found that a large number of lupus patients had red blood cells with detectable levels of mitochondria—and these cells were especially frequent in patients with the most severe lupus symptoms.
MELAS syndrome is a rare disorder that affects males and females in equal numbers. Although rare, MELAS syndrome is probably the most common type of mitochondrial myopathy caused by mutations in mtDNA.
The main symptoms of mitochondrial myopathy are muscle fatigue, weakness, and exercise intolerance. The severity of any of these symptoms varies greatly from one person to the next, even in the same family. In some individuals, weakness is most prominent in muscles that control movements of the eyes and eyelids.
Type-1 Excludes mean the conditions excluded are mutually exclusive and should never be coded together. Excludes 1 means "do not code here."
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code E88.4. Click on any term below to browse the alphabetical index.